Balance Sheet Data
Takeda Pharmaceutical Company Limit... (TAK)
$14.02
-0.07 (-0.50%)
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Total Cash | 725,369 | 653,435.99 | 1,002,820 | 874,999.99 | 553,704 | 1,195,581.62 | 1,430,355.63 | 1,711,231.74 | 2,047,262.95 | 2,449,279.94 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 749,119 | 784,920.99 | 812,714.01 | 724,376.98 | 681,692.98 | 1,177,659.49 | 1,408,914.17 | 1,685,579.87 | 2,016,573.87 | 2,412,564.50 |
| Account Receivables (%) | ||||||||||
| Inventories | 986,744 | 759,598.99 | 753,881.01 | 853,166.99 | 986,456.99 | 1,369,400.41 | 1,638,306.88 | 1,960,017.97 | 2,344,902.84 | 2,805,366.79 |
| Inventories (%) | ||||||||||
| Accounts Payable | 212,348 | 318,816 | 343,837.99 | 516,297.01 | 649,233 | 589,290.07 | 705,007.80 | 843,448.79 | 1,009,075.17 | 1,207,225.27 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -134,113.99 | -217,710.01 | -236,468 | -186,037.01 | -633,688.99 | -398,488.44 | -476,738.82 | -570,355.09 | -682,354.59 | -816,347.22 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.